In vitro demonstration of potential virulence determinants among clinical isolates of various Candida species and its clinical implication in a Teaching Hospital in Eastern India
used. [2] The adherence assay as described by Kimura and Pearsall [4] and biofilm production by visual method [5] were followed. ATCC Candida parapsilosis 90661 and ATCC Candida albicans 40028 were taken as controls. 40 were C. albicans, 30 C. tropicalis, 22 C. parapsilosis, 12 C. lusitaniae, 8 C. glabrata, 6 C. krusei and 2 C. stellatoidea. Fifty-nine (49.1%) isolates showed haemolysin production, 53 (44.1%) expressed phospholipase, 38 (31.6%) expressed esterase, 47 (39.1%) strains gave positive result in adherence assay and 58 (48.3%) Candida isolates were biofilm producers. Expression of virulence markers was found in 28/40 (70%) strains of C. albicans, whereas only 36/80 (45%) of non-albicans Candida strains showed the same.
There is a significant increase in the incidence of Candidiasis over the past two decades.
C. albicans (33.3%) was the most commonly isolated species in the present study. Non-albicans Candida spp. (66.7%) exceeded the total isolated C. albicans (33.3%).
Significant statistical valuation was arrived at when C. albicans and non-albicans Candida strains were compared for expression of virulence traits (P = 0.0118, odds ratio 2.852, 95% confidence interval 1.272-6.393) which is in accordance with the previous studies of Inci et al., 2012 [2] and Gokce et al., 2007 . [5] They also found significantly higher expression of virulence factors among albicans than non-albicans Candida. In our study, haemolysin was the major virulence factor expressed by Candida isolates 59 (49.1%) irrespective of its species. However, the results of interspecies Dear Editor, Over the last three decades, Candida species has emerged as an important cause of healthcare-associated and opportunistic infection. [1] The present study was intended to identify different species of Candida isolated from clinical specimens and to examine their potential virulence determinants in vitro which might help in clinical correlation to administer rational and justified therapy.
One hundred and twenty Candida spp. were isolated from various clinical specimens following standard protocol. Among all the isolates, 43 were obtained from nail samples, 22 from blood, 14 from deep tracheal aspirate and bronchoalveolar lavage samples, 23 from oral swabs or buccal washings of immunocompromised patients, ten from buccal ulcer samples, six from urine and two from gastric lavage samples.
Yeast suspension was prepared to evaluate different virulence factors. The turbidity was matched to 0.5 McFarland standards. [2] For determination of phospholipase activity, egg yolk agar media, [2] Sabouraud Dextrose Agar containing 7% blood and 3% glucose for haemolytic activity [3] and tween 80 opacity test media for detection of esterase activity were
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. [3] In the present study, 23/40 (57.5%) strains of C. albicans were biofilm producers while 35/80 (43.75%) non-albicans Candida strains were biofilm positive, an observation which corroborates with Yigit et al. [3] Virulence of Candida may vary as it depends on the type of species and the clinical sample from which it has been isolated [ Figure 1 ]. Hence, the significance of virulence determination in rational antifungal therapy cannot be ignored and should be adopted as a routine procedure in the laboratory.
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